Peripheral T-Cell Lymphomas Respond Well to Vincristine, Adriamycin, Cyclophosphamide, Prednisone and Etoposide (VACPE) and Have a Similar Outcome as High-Grade B-Cell Lymphomas

References

• Greer J. P., York J. C., Cousar J. B., Mitchell R. T., Flexner J. M., Collins R. D., Stein R. S. Peripheral T-cell lymphoma: a clinicopathologic study of 42 cases. J. Clin. Oncol. 1984; 2: 788–798
   PubMed Web of Science ®Google Scholar
• Broder S., Bunn P. A., Jaffe E. S., Blattner W., Gallo R. C., Wong-Staal F., Waldmann T. A., De Vita V. T., Jr. T-cell lymphoproliferative syndrome associated with human T-cell leukemia/lymphoma virus. Ann. Intern. Med. 1984; 100: 543–557
   PubMed Web of Science ®Google Scholar
• Stansfeld A. G., Diebold J., Noel H., Kapanci Y., Rilke F., Kelényi G., Sundstrom C., Lennert K., Van Unnik J. A. M., Mioduszewska O., Wright D. H. Updated Kiel classification for lymphomas. Lancet 1988; 1: 292–293
   PubMed Web of Science ®Google Scholar
• Harris N. L., Jaffe E. S., Stein H., Banks P. M., Chan J. K. C., Cleary M. L., Delsol G., De Wolf-Peeters C., Falini B., Garter K. C., Grogan T. M., Isaacson P. G., Knowles D. M., Mason D. Y., Muller-Hermelink H. K., Pileri S. A., Piris M. A., Ralfkiaer E., Warnke R. A. A Revised European-American Classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361–1392
   PubMed Web of Science ®Google Scholar
• Waldron J. A., Leech J., Glick A. D., Flexner J. M., Collins R. D. Malignant lymphoma of peripheral T-lymphocyte origin. Immunologic, pathologic, and clinical features in six patients. Cancer 1977; 40: 1604–1617
   PubMed Web of Science ®Google Scholar
• Lob S., Bergmann L., Müller H., Hoelzer D. Pleomorphes T-Zell Lymphom. Deutsch. Med. Wochschr. 1991; 25: 986–991
   Web of Science ®Google Scholar
• Lob S., Bergmann L., Müller H., Jacobi V., Hoelzer D. Pleomorphes T-Zell Lymphom. Deutsch. Med. Wochschr. 1993; 118: 780–784
   PubMed Web of Science ®Google Scholar
• Garam T., Bak M., Bakacs T., Döbrentei E., Petranyi G. Angioimmunoblastic lymphadenopathy: a study of the function of lymphocyte populations. Cancer 1981; 47: 2850–2855
   PubMed Web of Science ®Google Scholar
• Lennert K., Feller A. C. Histopathologie der Non-Hodgkin-Lymphome. Springer Verlag, Berlin 1990
   Google Scholar
• Patsouiris E., Engelhard M., Zwingers T., Lennert K. Lymphoepitheloid cell lymphoma (Lennert's lymphoma): clinical features derived from analysis of 108 cases. Br. J. Haematol. 1993; 84: 346–348
   PubMed Web of Science ®Google Scholar
• Schlegelberger B., Feller A. C. Classification of peripheral T-cell lymphomas: cytogenetic findings support the Updated Kiel classification. Leuk. Lymphoma 1996; 20: 411–416
   PubMed Web of Science ®Google Scholar
• Weiss L. M., Grabtree G. S., Rouse R. V., Warnke R. A. Morphological and immunologic characterization of 50 peripheral T-cell lymphomas. Am. J. Pathol. 1985; 118: 316–324
   PubMed Web of Science ®Google Scholar
• Mirchandani I., Palutke M., Tabaczka P., Goldfarb S., Eisenberg L, Pak M. S. B-cell lymphomas morphologically resembling T-cell lymphomas. Cancer 1985; 56: 1578–1583
   PubMed Web of Science ®Google Scholar
• Banks P. M. Hematology/Oncology clinics of North America. Non-Hodgkin's Lymphoma. 1991; 935–952
   Google Scholar
• Neilly I. J., Bennett N. B., Dawson A. A., King D. J., Gatto G. R. Systemic hypertension—an unusal presentation of T-cell lymphoma. Clin. Lab. Haematol. 1994; 16: 75–78
   PubMedGoogle Scholar
• Lippman S. M., Miller T. P., Spier C. M., Slymen D. J., Grogan T. M. The prognostic significance of the immunotype in diffuse large-cell lymphoma: a comparative study of t-cell and B-cell phenotype. Blood 1988; 72: 436–141
   PubMed Web of Science ®Google Scholar
• Coiffier B., Bryon P. A., Ffrench M., Blanc M., Sebban C., Berger F., Viala J. J. Intesive chemotherapy in aggressive lymphomas. Updated results of LNH-80 protocol and prognostic factors affecting response and survival. Blood 1987; 70: 1394–1399
   PubMed Web of Science ®Google Scholar
• Cheng A. L., Chen Y. C., Wang C. H., Su I. H., Hsieh H. C., Chang J. Y., Hwang W. S., Su W. H., Liu T. W., Tien H. F., Tsai W., Shen M. C., Liu C. H. Direct comparison of peripheral T-cell lymphoma with diffuse B-cell lymphoma of comparable histological grades—Should peripheral T-cell lymphoma be considered separately?. J. Clin. Oncol. 1989; 7: 725–731
   PubMed Web of Science ®Google Scholar
• Liang R., Todd D., Chen T. K., Wang K. L., Ho F., Loke S. L. Peripheral T-cell lymphoma. J. Clin. Oncol. 1987; 5: 750–755
   PubMed Web of Science ®Google Scholar
• Kwak L. W., Wilson M., Weiss M. W., Doggett R., Dorfman R. F., Warnke R. A., Horning S. J. Similar outcome of treatment of B-cell and T-cell diffuse large-cell lymphomas: The Stanford experiment. J. Clin. Oncol. 1991; 8: 1426–1431
   Google Scholar
• Coiffier B., Brousse N., Peuchmaur M., Berger F., Gisselbrecht C., Bryon P. A., Diebold J. Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: a prospective study of 361 immunophenotyped patients treated with the LNH-84 regimen. Ann. Oncol. 1990; 1: 45–50
   PubMed Web of Science ®Google Scholar
• Horning S. J., Weiss L. M., Crabtree G., Warnke R. A. Clinical and phenotypic diversity of T-cell lymphomas. Blood 1986; 67: 1578–1582
   PubMed Web of Science ®Google Scholar
• Bergmann L., Karakas T., Lautenschläger G., Jäger E., Knuth A., Mitrou P. S., Hoelzer D. Vincristine, doxorucin, cyclophosphamide, prednisone, etoposide (VACPE) in high-grade Non-Hodgkin's lymphoma—a multi-center phase II study. Ann. Oncol. 1995; 6: 1019–1024
   PubMed Web of Science ®Google Scholar
• Carbone P. P., Kaplan H. S., Musshoff K., Smithers D. W., Tubiana M. Report of the committee on Hodgkin's disease staging. Cancer Res. 1971; 31: 1860–1861
   PubMed Web of Science ®Google Scholar
• The International Non-Hodgkin's lymphoma prognostic factors project. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma prognostic factors project. N. Engl. J. Med. 1993; 329: 987–994
   PubMed Web of Science ®Google Scholar
• Bergmann L., Karakas T., Knuth A., Lautenschläger G., Mitrou P. S., Hoelzer D. Recombinant human granulocyte-macrophage colony-stimulating factor after combined chemotherapy in high-grade non-Hodgkin's lymphomas—A randomized pilot study. Eur. J. Cancer 1995; 31A: 2164–2168
   PubMed Web of Science ®Google Scholar
• Kaplan E. M., Meier P. Non-parametric estimation from incomplete observations. J. Am. Stat. Ass. 1958; 53: 457–481
   Web of Science ®Google Scholar
• Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep. 1966; 50: 163–170
   PubMedGoogle Scholar
• Fisher R. I., Gaynor E. R., Dahlberg S., Oken M. M., Grogan T. M., Mize E. M., Glick J. H., Coltman C. A., Jr., Miller T. P. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced Non-Hodgkin's lymphomas. N. Engl. J. Med. 1993; 328: 1002–1006
   PubMed Web of Science ®Google Scholar
• Kwak L. W., Halpern J., Olshen I., Horning S. J. Prognostic significance of actual dose intensitiy in diffuse large-cell lymphoma: results of a tree-structured survival analysis. J. Clin. Oncol. 1990; 8: 963–977
   PubMed Web of Science ®Google Scholar
• Lepage E., Gisselbrecht C., Haioun C., Sebban C., Tilly H., Bosly A., Morel P., Herbrecht R., Reyes F., Coiffier B. Prognostic significance of received relative dose intensitiy in non-Hodgkin's lymphoma patients; Application to LNH-87 protocol. Ann. Oncol. 1993; 4: 651–656
   PubMed Web of Science ®Google Scholar
• Coiffier B., Berger F., Bryon P. A., Magand J. P. T-cell lymphomas: immunologic, histologic, clinical, and ther-apeutic analysis of 63 cases. J. Clin. Oncol. 1988; 6: 1584–1589
   PubMed Web of Science ®Google Scholar
• Siegert W., Agthe A., Griesser H., Schwerdtfeger R., Brittinger G., Engelhard M., Kuse R., Tiermann M., Lennert K., Huhn D. Treatment of angioimmunoblastic lymphadenopathy (AILD)-type t-cell lymphoma using prednisone with or without the COPBLAM/IMVP-16 regimen. Ann. Int. Med. 1992; 117: 364–370
   PubMed Web of Science ®Google Scholar
• Lennert K., Feller A. C. Histopathologie der Non-Hodgkin-Lvmphome. Springer Verlag, Berlin 1990
   Google Scholar
• De Bruin P. C., Noorduyn A. L., Van der Valk P., Van der Falk P., Van Heerde P., Van Diest P. J., Van de Sandt M. M., Ossenkoppele G. J., Meijer C. J. L. M. Noncutaneous T-cell lymphomas. Recognition of a lymphoma type (large cell anaplastic) with a relatively favorable prognosis. Cancer 1993; 71: 2604–2612
   PubMed Web of Science ®Google Scholar
• D'Agay M. F., Briere J., Lepage E. Primary anaplastic large cell Non Hodgkin's lymphoma (A.L.C.L.) in adults: a clinicopathological study of 122 cases compared to a cohort of 1173 non anaplastic large cell lymphoma. A GELA study. Blood 1993; 82: 525, Suppl. 1
   Google Scholar
• Van den Oord J. J., De Wolf-Peeters C., Frizzera G., Desmet V. J., Tricot G., Thomas J., Marten K., Gatter K. C., Mason D. Y. T-helper cell lymphoma involving the lymph nodes and skin. A clinical, morphologic, and immunohistochemical analysis of five cases. Cancer 1985; 55: 1714–1721
   PubMed Web of Science ®Google Scholar
• Ramsay A. D., Smith W. J., Earl H. M., Souhami R. L., Isaacson P. G. T-cell lymphomas in adults: a clinicopathological study of eighteen cases. J. Path. 1987; 152: 63–76
   PubMed Web of Science ®Google Scholar
• Brisbane J. U., Berman L. D., Neimann R. S. Peripheral T-cell lymphoma. A clinicopathologic study of nine cases. Am. J. Clin. Pathol. 1985; 79: 285–293
   Web of Science ®Google Scholar
• Armitage J. O., Greer J. P., Levine A. M., Weisenburger D. D., Formenti S. C., Bast M., Conley S., Pierson J., Linder J., Cousar J. B., Nathwani B. N. Peripheral T-cell lymphoma. Cancer 1989; 63: 158–163
   PubMed Web of Science ®Google Scholar
• Liang R., Chiu E., Chan T. K., Todd D., Loke S. L. Direct comparison of peripheral T-cell lymphoma with their B-cell counterparparts. Acta. Haematol. 1991; 85: 179–183
   PubMed Web of Science ®Google Scholar